The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-05-01
|
| Series: | Trials |
| Online Access: | http://link.springer.com/article/10.1186/s13063-020-04407-x |
| id |
doaj-cbf0e227b341448088ede7f244031fd7 |
|---|---|
| record_format |
Article |
| spelling |
doaj-cbf0e227b341448088ede7f244031fd72020-11-25T03:06:12ZengBMCTrials1745-62152020-05-012111310.1186/s13063-020-04407-xThe COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trialEoin Feeney0Deborah Wallace1Aoife Cotter2Willard Tinago3Cormac McCarthy4David Keane5Rabia Hussain6Elena Alvarez Barco7Peter Doran8Patrick Mallon9St Vincent’s University HospitalSchool of Medicine, University College DublinSchool of Medicine, University College DublinSchool of Medicine, University College DublinSt Vincent’s University HospitalSt Vincent’s University HospitalSchool of Medicine, University College DublinSchool of Medicine, University College DublinSchool of Medicine, University College DublinSt Vincent’s University Hospitalhttp://link.springer.com/article/10.1186/s13063-020-04407-x |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Eoin Feeney Deborah Wallace Aoife Cotter Willard Tinago Cormac McCarthy David Keane Rabia Hussain Elena Alvarez Barco Peter Doran Patrick Mallon |
| spellingShingle |
Eoin Feeney Deborah Wallace Aoife Cotter Willard Tinago Cormac McCarthy David Keane Rabia Hussain Elena Alvarez Barco Peter Doran Patrick Mallon The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial Trials |
| author_facet |
Eoin Feeney Deborah Wallace Aoife Cotter Willard Tinago Cormac McCarthy David Keane Rabia Hussain Elena Alvarez Barco Peter Doran Patrick Mallon |
| author_sort |
Eoin Feeney |
| title |
The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial |
| title_short |
The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial |
| title_full |
The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial |
| title_fullStr |
The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial |
| title_full_unstemmed |
The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial |
| title_sort |
covirl-001 trial: a multicentre, prospective, randomised trial comparing standard of care (soc) alone, soc plus hydroxychloroquine monotherapy or soc plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, sars-cov-2 pcr-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: a structured summary of a study protocol for a randomised controlled trial |
| publisher |
BMC |
| series |
Trials |
| issn |
1745-6215 |
| publishDate |
2020-05-01 |
| url |
http://link.springer.com/article/10.1186/s13063-020-04407-x |
| work_keys_str_mv |
AT eoinfeeney thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT deborahwallace thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT aoifecotter thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT willardtinago thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT cormacmccarthy thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT davidkeane thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT rabiahussain thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT elenaalvarezbarco thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT peterdoran thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT patrickmallon thecovirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediate AT eoinfeeney covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres AT deborahwallace covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres AT aoifecotter covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres AT willardtinago covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres AT cormacmccarthy covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres AT davidkeane covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres AT rabiahussain covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres AT elenaalvarezbarco covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres AT peterdoran covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres AT patrickmallon covirl001trialamulticentreprospectiverandomisedtrialcomparingstandardofcaresocalonesocplushydroxychloroquinemonotherapyorsocplusacombinationofhydroxychloroquineandazithromycininthetreatmentofnoncriticalsarscov2pcrpositivepopulationnotrequiringimmediateres |
| _version_ |
1724674711407820800 |